Crescence, L.; Kramberg, M.; Baumann, M.; Rey, M.; Roux, S.; Panicot-Dubois, L.; Dubois, C.; Riederer, M.A.
The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo. J. Clin. Med. 2021, 10, 5349.
https://doi.org/10.3390/jcm10225349
AMA Style
Crescence L, Kramberg M, Baumann M, Rey M, Roux S, Panicot-Dubois L, Dubois C, Riederer MA.
The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo. Journal of Clinical Medicine. 2021; 10(22):5349.
https://doi.org/10.3390/jcm10225349
Chicago/Turabian Style
Crescence, Lydie, Markus Kramberg, Martine Baumann, Markus Rey, Sebastien Roux, Laurence Panicot-Dubois, Christophe Dubois, and Markus A. Riederer.
2021. "The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo" Journal of Clinical Medicine 10, no. 22: 5349.
https://doi.org/10.3390/jcm10225349
APA Style
Crescence, L., Kramberg, M., Baumann, M., Rey, M., Roux, S., Panicot-Dubois, L., Dubois, C., & Riederer, M. A.
(2021). The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo. Journal of Clinical Medicine, 10(22), 5349.
https://doi.org/10.3390/jcm10225349
